Lilly's triple agonist, retatrutide, delivered powerful weight loss in pivotal Phase 3 obesity trialPRNewsWire • 05/21/26
Focus: Lower cost Novo, Lilly weight-loss pills draw patients from compounded drugs, doctors sayReuters • 05/21/26
Eli Lilly accuses church bishops, businessmen of fraud in Trulicity drug rebate schemeCNBC • 05/20/26
These 15 S&P 500 stocks could be contrarian ways to play the market's uneven rallyMarket Watch • 05/20/26
Watch Out, Eli Lilly and Novo Nordisk: Viking Therapeutics' Pill Could Crash the Weight-Loss PartyThe Motley Fool • 05/19/26
As millions flock to GLP-1s, doctors warn of a rise in frailty caused by rapid muscle wastingWSJ • 05/17/26
Could Eli Lilly's Next Weight Loss Drug Waylay Wegovy -- and Even Zap Zepbound?The Motley Fool • 05/17/26
Lilly, Caitlin Clark Foundation, and Musco Lighting open three community sports courts in Indianapolis, expanding year-round access for youthPRNewsWire • 05/16/26